Internal Medicine, Hematology & Oncology · El Paso, TX
NPI
1306923180
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3270 Joe Battle Blvd Ste 312
El Paso, TX, 79938
Phone (915) 747-4877
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
71,459 services
Medicare patients, 2024
479
Average age 74
Drug cost, 2024
$15.6M
4,144 prescriptions
Company payments, 2025
$11K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria C Aloba was code J1453 (injection, fosaprepitant, 1 mg), 5,400 times for 19 patients. In total Maria C Aloba billed 71,459 services in 141 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,400 | 19 | $0.11 | $570 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,882 | 28 | $0.10 | $282 |
| 36415 Venipuncture Blood Collection | Office | 1,670 | 307 | $8.65 | $14K |
| 85025 Blood Count | Office | 1,535 | 304 | $7.61 | $12K |
| 80053 Clinical Chemistry | Office | 1,505 | 304 | $10.35 | $16K |
| 83615 Clinical Chemistry | Office | 1,216 | 289 | $5.92 | $7,199 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 720 | 33 | $0.09 | $62.15 |
| 99214 Office E&M - Established | Office | 605 | 223 | $92.91 | $56K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 423 | 54 | $73.33 | $31K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 410 | 19 | $0.68 | $277 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 403 | 147 | $12.34 | $4,971 |
| 99232 Hospital E&M - Subsequent | Facility | 335 | 94 | $58.63 | $20K |
| J9190 Injection, fluorouracil, 500 mg | Office | 284 | 15 | $2.19 | $621 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 270 | 12 | $0.25 | $66.37 |
| 85055 Blood Count | Office | 220 | 69 | $35.03 | $7,707 |
By year: 2022 $2.3M for 143,706 services; 2023 $1.8M for 108,507 services; 2024 $1.4M for 71,459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,670 | 307 | $8.65 | $14K |
| 85025 Blood Count | 1,535 | 304 | $7.61 | $12K |
| 80053 Clinical Chemistry | 1,505 | 304 | $10.35 | $16K |
| 83615 Clinical Chemistry | 1,216 | 289 | $5.92 | $7,199 |
| 85055 Blood Count | 220 | 69 | $35.03 | $7,707 |
| 86300 Immunoassay | 142 | 59 | $20.39 | $2,895 |
| 83550 Clinical Chemistry | 127 | 85 | $8.57 | $1,088 |
| 82728 Clinical Chemistry | 127 | 85 | $13.36 | $1,697 |
| 83540 Clinical Chemistry | 127 | 85 | $6.34 | $805 |
| 85007 Blood Count | 106 | 34 | $3.72 | $394 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria C Aloba prescribed most often to Medicare patients was Dexamethasone, with 346 prescriptions and refills. In total Maria C Aloba wrote 4,144 Medicare prescriptions that cost $15.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 346 | 358 | 94 | $2,530 |
| Exemestane Generic | 281 | 458 | 76 | $33K |
| Acyclovir Generic | 234 | 247 | 39 | $1,350 |
| Ondansetron Odt Ondansetron | 202 | 202 | 106 | $2,349 |
| Revlimid Lenalidomide | 174 | 174 | 32 | $3.0M |
| Letrozole Generic | 158 | 298 | 43 | $2,821 |
| Potassium Chloride Generic | 150 | 150 | 85 | $321 |
| Eliquis Apixaban | 147 | 175 | 45 | $100K |
| Prednisone Generic | 132 | 142 | 44 | $415 |
| Olanzapine Generic | 126 | 126 | 48 | $528 |
| Ibrance Palbociclib | 120 | 124 | 21 | $2.0M |
| Gabapentin Generic | 113 | 138 | 41 | $1,286 |
| Levothyroxine Sodium Generic | 107 | 157 | 26 | $701 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 84 | 84 | 61 | $1,084 |
| Xtandi Enzalutamide | 82 | 82 | 15 | $1.1M |
Brand drugs: 1,172 claims; generic drugs: 2,972 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria C Aloba $11K ($11K in general payments such as food, travel and fees) from 8 companies. The largest payer was Exelixis Inc. with $3,276.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.